Relay Therapeutics, Inc. RLAY Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s total operating expenses?
- Relay Therapeutics, Inc. (RLAY) reported total operating expenses of $81.59M in Q1 2026.
- How has Relay Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Relay Therapeutics, Inc.'s total operating expenses decreased by 11.8% year-over-year, from $92.55M to $81.59M.
- What is the long-term trend for Relay Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s total operating expenses has grown at a -3.6% compound annual growth rate (CAGR), from $367.73M to $318.09M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.